Variable | Mean ± DS† | ||
---|---|---|---|
Age [years] | 53.8 ± 12.3 | ||
BMI* [kg/m 2 ] | 25.5 ± 3.7 | ||
N (%) | |||
History of | COPD | ||
I (mild) | FEV1/FVC < 70% and FEV1/FEV1 predicted > 80% | 2 (5) | |
II (moderate) | FEV1/FVC < 70% and 50% ≤ FEV1/FEV1 predicted < 80% | 7 (18) | |
III (severe) | FEV1/FVC < 70% and 30% ≤ FEV1/FEV1 predicted < 50% | 5 (13) | |
Chronic bronchitis† | 29 (76) | ||
Emphysema† | 5 (13) | ||
Bronchial asthma† | 20 (53) | ||
Coronary heart disease† | 11 (29) | ||
Angina pectoris† | 15 (40) | ||
Myocardial infarction† | 8 (21) | ||
Bypass surgery/balloon dilatation† | 4 (11) | ||
Hypertension† | 14 (37) | ||
Chronic heart failure† | 2 (5) | ||
Cardiac arrest† | 1 (3) | ||
Diabetes mellitus Type 2† | 2 (5) | ||
Allergic rhinitis† | 11 (29) | ||
Sleep apnea† | 4 (11) | ||
Chronic kidney disease† | 2 (5) | ||
Smoking history | Ex smoker | 23 (61) | |
Current smoker | 7 (18) | ||
Long-term medication use | Patients with long-term medication | 35 (92) | |
β2-agonists | 22 (58) | ||
Theophylline | 17 (45) | ||
Glucocorticosteroids | 20 (53) | ||
Antibiotics | 5 (13) | ||
Statins | 6 (16) |